BIOVANTAGE.DK ApS: Financial statements 2020
CVR: 36498544
Source: annual report 2020, Danish Business Authority
01/07/2019 – 30/06/2020
BIOVANTAGE.DK ApS (CVR 36498544) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 3,276,866 and a net result of DKK -1,137,647 compared with DKK -1,863,505 the year before. That is an increase of 23% compared with the year before. Equity in the 2020 report amounted to DKK -7,002,892. The company had 2 employees in the financial year.
- Gross Profit
- DKK 3,276,866
- Profit/Loss
- DKK -1,137,647
- Equity
- DKK -7,002,892
- Total Assets
- DKK 7,835,482
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | 3.3 mio. | -1.1 mio. | -7 mio. | 2 |
| 2019 | - | 2.7 mio. | -1.9 mio. | -5.9 mio. | 1 |
| 2018 | - | 3 mio. | -1.5 mio. | -4 mio. | 2 |
| 2017 | - | 2.7 mio. | -2 mio. | -2.5 mio. | - |
Official annual report
How creditworthy is BIOVANTAGE.DK ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreAbout BIOVANTAGE.DK ApS
BIOVANTAGE.DK ApS was a Danish company of the type Anpartsselskab based in København K, founded in 2015. The company has been dissolved on 30 December 2025. The company was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company has 1 employee (2021). In 2023, the company reported a gross profit of DKK -243,628 and a net result of DKK -612,916 compared with DKK -264,925 the year before. Equity in the 2023 report amounted to DKK -5,792,487.